Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cybin Inc
(NY:
CYBN
)
0.2680
+0.0007 (+0.26%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Cybin Announces Initiation of Kernel Flow® Feasibility Study Measuring Psychedelic Effects on the Brain
March 31, 2022
From
Cybin Inc.
Via
Business Wire
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Milestone in CYB003 Program
March 30, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Significant Milestone Toward Advancing CYB003 Program
March 29, 2022
Via
Investor Brand Network
New Research Reveals How Psychedelics Are Helping Combat Mental Illness
March 29, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily,...
Via
FinancialNewsMedia
Cybin Announces Successful Completion of In Vivo Preclinical Studies for its Deuterated Psilocybin Analog CYB003 Supporting Advancement into Phase 1/2a Clinical Trial
March 29, 2022
From
Cybin Inc.
Via
Business Wire
Cybin (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone
March 25, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Subsidiary Achieves Milestone Outlined in Contribution Agreement
March 25, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
March 25, 2022
From
Cybin Inc.
Via
Business Wire
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Commences Participant Recruitment in Feasibility Study Using Kernel Flow Technology
March 24, 2022
Via
Investor Brand Network
Cybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting Participants
March 24, 2022
From
Cybin Inc.
Via
Business Wire
Cybin (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004
March 22, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Planning Pilot Study of CYB004, Pursuing Multiple Opportunities to Secure, Support Patent Position for R&D
March 21, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) on Leading Edge of Development of Psychedelics as Public Support Grows
March 17, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Participation in Upcoming Maxim Group Virtual Growth Conference
March 16, 2022
Via
Investor Brand Network
Cybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022
March 16, 2022
From
Cybin Inc.
Via
Business Wire
Cybin (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
March 10, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Eyes Potential of First-of-Its-Kind Study
March 09, 2022
Via
Investor Brand Network
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
March 07, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Chopra Foundation Partner in Efforts to Support Progress Toward Psychedelic-Based Therapeutics
March 07, 2022
Via
Investor Brand Network
Cybin (NYSE American: CYBN) (NEO: CYBN) Teams with Chopra Foundation to Foster Psychedelics Awareness
March 03, 2022
Via
Investor Brand Network
Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Teams Up with Chopra Foundation to Foster Psychedelics Therapy Awareness
March 02, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) CEO to Participate in Fireside Chat at Oppenheimer Annual Healthcare Conference
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Via
Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of...
Via
FinancialNewsMedia
Cybin’s (NYSE American: CYBN) (NEO: CYBN) Study to Potentially Open New Frontiers in Psychedelics
February 28, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Feasibility Study to Potentially Open New Frontiers of Understanding Psychedelics
February 25, 2022
Via
Investor Brand Network
Cybin (NEO: CYBN) (NYSE American: CYBN) Reports Adelia Milestone
February 22, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports Achievement of Additional Adelia Milestone
February 18, 2022
Via
Investor Brand Network
Cybin Announces Additional Adelia Milestone Achievement
February 18, 2022
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.